Amgen 🧪🔬🧬

Every story is personal. Every voice can help bring our mission into focus. Meet people whose experiences with cancer, cardiovascular disease, rare disease and obesity have shaped their lives and perspectives. At Amgen, serving patients is our mission. We’re honored to be named to @TIME World’s Best Companies 2026 list:

Amgen will report Q3 2026 financial results on Tuesday, November 3. Details here: $AMGN

Innovation has deep roots in Massachusetts, and Amgen is proud to have been part of its life sciences community for 25 years. From our research center in Cambridge, our teams continue to push the boundaries of science to advance medicines for patients around the world. Learn more about our history in Massachusetts:

Amgen today announced the appointment of David W. Gibbs, former president and CEO of Yum! Brands, to its Board of Directors. He brings experience leading global consumer brands and building direct customer relationships.

#NEWS: At #ESMO26, Amgen presents late-breaking data for our DLL3-targeting T-cell engager, with findings simultaneously published in @NEJM. These landmark results add to our growing body of evidence across the #SCLC treatment journey. Read more: $AMGN

🔬 Research to watch at @myESMO’s #ESMO26. We're sharing new data across small cell lung cancer (SCLC) and our broader T-cell engager pipeline, including late-breaking research. Search for abstracts LBA3, 3821P and 3808O:

📢 Amgen announced positive full Phase 3 results in eosinophilic esophagitis (EoE), a chronic inflammatory disorder of the esophagus that can make swallowing and eating challenging. 🔗 Learn more: $AMGN

What would it take to close post-fracture care gaps in postmenopausal osteoporosis? At #ASBMR2026, Amgen leaders are weighing in on where action is needed to strengthen care coordination and help reduce the risk of future fractures. Explore their perspectives now.

🔬Will you be at #ASBMR2026? Explore our latest real-world data highlighting encouraging new insights on changes in hip bone strength in postmenopausal women: 📊 Plenary Poster Session: Fri, Oct. 9 | 5:30–7:00 PM 📊 Poster Session I: Sat, Oct. 10 | 2:00–3:30 PM

Biosimilars have the potential to save the U.S. healthcare system $180B by the end of 2027, but bringing a biosimilar to patients not an easy journey. In fact, it can take 6-9 years and cost hundreds of millions of dollars. Follow the journey here to see exactly what it takes:

What do people living with obesity need for their long-term care? We’re at @EASDNews talking about patient-centered care and research. See what we’re discussing. ➡️ #EASD2026

📢 #SjogrensDisease News: Amgen announced that a Phase 3 study evaluating its investigational therapy in patients with moderate-to-severe systemic disease activity met its primary endpoint: $AMGN

RT @SU2C: We stand up for every child affected by cancer. 🧡 That’s why #StandUpToCancer teamed up with @MrBeast and @BeastPhilanthr to create a new SU2C Pediatric Cancer Dream Team focused on finding cures for kids with cancer, fueled by support from @Amgen and @StBaldricks. This #ChildhoodCancerAwarenessMonth, help end pediatric cancer by donating at

SCLC #NEWS: The @FDA approved a label update to the administration information for Amgen’s DLL3-targeting T-cell engager for certain patients with extensive-stage small cell lung cancer (ES-SCLC). 🔗Learn more: $AMGN

💡What does progress in small cell lung cancer (SCLC) look like? At #WCLC26, we’re excited to share our latest research including data from across several studies in small cell lung cancer. Learn more:

On the 25th anniversary of September 11, we remember Dora Menchaca—an Amgen scientist, mentor, mother, wife, and daughter who was aboard Flight 77—along with all the lives lost that day. 🔗

📢 #SCLC news: Amgen announced that a Phase 3 study evaluating its DLL3-targeting therapy as part of first-line maintenance treatment for patients with extensive-stage small cell lung cancer met its primary endpoint ➡️ Learn more: $AMGN

At Amgen, sustainability is built into how we work. From reducing energy and water use to improving the efficiency of making medicines, environmental sustainability is embedded into our operations. Learn more:

Years of waiting. That’s how long it can take to get a Thyroid Eye Disease (TED) diagnosis. At @ETA_Thyroid’s Annual Meeting, we’re sharing our latest advances in TED and exploring how to help people get answers sooner. Learn more from the experts.